Discovery could lead to more potent garlic, boosting flavor and bad breath
For centuries, people around the world have used garlic as a spice, natural remedy, and pest deterrent – but they didn’t know how powerful or pungent the heads of garlic were until they tasted them.
But what if farmers were able to grow garlic and know exactly how potent it would be? What if buyers could pick their garlic based on its might?
A team of Virginia Tech researchers recently discovered a new step in the metabolic process that produces the enzyme allicin, which leads to garlic’s delectable flavor and aroma, a finding that upends decades of previous scientific belief. Their work could boost the malodorous - yet delicious - characteristics that garlic-lovers the world over savor.
“This information changes the whole story about how garlic could be improved or we could make the compounds responsible of its unique flavor,” said Hannah Valentino, a College of Agriculture and Life Sciences Ph.D. candidate. “This could lead to a new strain of garlic that would produce more flavor.”
The discovery of this pathway opens the door for better control of production and more consistent crops, which would help farmers. Garlic could be sold as strong or weak, depending on consumer preferences.
The research was recently published in the Journal of Biological Chemistry.
When Valentino, an Institute for Critical Technology and Applied Science doctoral fellow, and her team set out to test the generally accepted biological process that creates allicin, they found it just didn’t happen.
That’s when the team of researchers set out to discover what was really happening in garlic.
As they peeled back the layers, they realized there was no fuel to power the previous accepted biological process that creates allicin.
“By using rational design, Hannah found a potential substrate,” said Pablo Sobrado, professor of biochemistry in the College of Agriculture and Life Sciences and a member of the research team. “This is significant because by finding the metabolic pathway and understanding how the enzyme actually works and its structure gives us a blueprint of how allicin is created during biosynthesis.”
Valentino and the team – which included undergraduate students – worked in the Sobrado Lab in the Fralin Life Sciences Institute directly with the substrates that comprise garlic, doing their work solely in vitro.
The researchers found that allicin, the component that gives garlic its smell and flavor, was produced by an entirely different biosynthetic process. Allyl-mercaptan reacts with flavin-containing monooxygenase, which then becomes allyl-sulfenic acid.
Importantly, the allicin levels can be tested, allowing farmers to know the strength of their crops without the need for genetic engineering. Greater flavor can simply be predicted, meaning powerful garlic could simply be bred or engineered.
“We have a basic understanding of the biosynthesis of allicin that it is involved in flavor and smell, but we also now understand an enzyme that we can try to modulate, or a modify, to increase or decrease the level of the flavor molecules based on these biological processes,” Sobrado said.
Because of their work, the future awaits for fields of garlic harsh enough to keep even the most terrifying vampires at bay.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Discoveries made possible by DNA
The discovery of DNA’s double helix revealed how genetic information is stored, copied and expressed. Revisit that breakthrough and traces how it laid the foundation for modern molecular biology, genomics and biotechnology.

Unraveling the language of histones
Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.

How Alixorexton could transform narcolepsy treatment
A new investigational drug, alixorexton, targets the brain’s orexin system to restore wakefulness in people with narcolepsy type 1. Alkermes chemist Brian Raymer shares how molecular modeling turned a lab idea into a promising phase 3 therapy.

Phosphatases and pupils: A dual legacy
Yale professor Anton Bennett explores how protein tyrosine phosphatases shape disease, while building a legacy of mentorship that expands opportunity and fuels discovery in biochemistry and molecular biology.

Extracellular vesicles offer clues to cattle reproduction
Extracellular vesicles from pregnant cattle support embryo development better than laboratory models, highlighting their potential to improve reproductive efficiency in bovine embryo cultures. Read more about this recent MCP paper.

Proteomics reveals protein shifts in diabetic eye disease
Using proteomics, researchers identified protein changes in eye fluid that mark diabetic retinopathy progression and may serve as biomarkers for vision-threatening complications. Read more about this recent MCP paper.